Oscar Health (OSCR) Current Deferred Revenue (2020 - 2026)

Oscar Health (OSCR) has 7 years of Current Deferred Revenue data on file, last reported at $172.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 142.61% year-over-year to $172.0 million; the trailing twelve-month figure through Mar 2026 stood at $172.0 million (up 142.61% YoY), and the FY2025 full-year result was $166.2 million, up 123.42% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $172.0 million, up from $166.2 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $172.0 million in Q1 2026 and bottomed at $60.0 million in Q2 2024.
• The 5-year median for Current Deferred Revenue is $73.1 million (2023), against an average of $82.8 million.
• The widest annual swing landed in 2024, when Current Deferred Revenue dropped 17.93%; it then jumped 142.61% in 2026.
• A 5-year view of Current Deferred Revenue shows it stood at $79.0 million in 2022, then dropped by 16.56% to $65.9 million in 2023, then grew by 12.85% to $74.4 million in 2024, then soared by 123.42% to $166.2 million in 2025, then gained by 3.49% to $172.0 million in 2026.
• The last three Current Deferred Revenue figures came in at $172.0 million (Q1 2026), $166.2 million (Q4 2025), and $77.1 million (Q3 2025), per Business Quant data.

Peer Comparison